A Randomised, Single-Blind, Three-Period Crossover Study Examining the Single Dose Pharmacokinetics of Concomitantly Administered Repaglinide and Metformin Versus Combination Tablet Dosing (NN4440) in Fed Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2015
At a glance
- Drugs Repaglinide/metformin (Primary) ; Metformin; Repaglinide
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 09 Dec 2009 Actual end date (1 Oct 2009) added as reported by ClinicalTrials.gov
- 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 31 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.